Stryker Corporation (SYK)
Stryker Corporation is a healthcare company focused on medical technology. As a common stock listing on the NYSE, the company develops and sells products for hospitals, doctors, and other healthcare facilities in the United States and abroad. Its operations are organized into two segments: MedSurg and Neurotechnology, and Orthopaedics.
The MedSurg and Neurotechnology segment includes surgical equipment, patient safety and communication technologies, navigation and endoscopic systems, patient handling and emergency care products, intensive care disposables, and solutions used in minimally invasive stroke and venous thromboembolism treatment. It also includes products for brain and skull-based procedures, along with orthobiologic and biosurgery products such as synthetic bone grafts and vertebral augmentation items. The Orthopaedics segment provides implants used in joint replacement, as well as trauma, extremities, and shoulder applications, including Mako Shoulder within its robotics-related portfolio.
Founded in 1941, Stryker is headquartered in Portage, Michigan, and distributes products through company-owned subsidiaries and branches, as well as third-party dealers and distributors in about 61 countries.
Jump directly to the stock analysis sections supported by the latest available data.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Dividend Yield | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NYSE-SYK
|
$354.48
|
15.4% Upside
|
Fair
|
$362.62
|
18.1% Upside
|
Undervalued
|
Great
|
1.1%
|
31.6x
|
4.9x
|
4.6x
|
117.8 B
|
129.8 B
|
11.6%
|
90.8%
|
6.8
|
35.3%
|
126.1%
|